Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.

  title={Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.},
  author={Marcel Klingenberg and Akiko Matsuda and Sven Diederichs and Tushar Patel},
  journal={Journal of hepatology},
  volume={67 3},
The majority of the human genome is not translated into proteins but can be transcribed into RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins, they contribute to diseases such as cancer. Here, we review examples of the functions of ncRNAs in liver cancer and their potential use for the detection and treatment of liver cancer. 
Related Discussions
This paper has been referenced on Twitter 32 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper


Publications citing this paper.
Showing 1-10 of 35 extracted citations

Human plasma and serum extracellular small RNA reference profiles and their clinical utility

Proceedings of the National Academy of Sciences of the United States of America • 2018


Publications referenced by this paper.
Showing 1-10 of 210 references

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.

Cytokine & growth factor reviews • 2010
View 6 Excerpts
Highly Influenced

Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.

Journal of hepatology • 2016
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…